Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection.

HIV aging computational biology infectious disease metabolomics microbiology microbiome systems biology viruses

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
16 02 2023
Historique:
received: 17 08 2022
accepted: 15 02 2023
pubmed: 17 2 2023
medline: 17 3 2023
entrez: 16 2 2023
Statut: epublish

Résumé

Multiomics technologies improve the biological understanding of health status in people living with HIV on antiretroviral therapy (PWH). Still, a systematic and in-depth characterization of metabolic risk profile during successful long-term treatment is lacking. Here, we used multi-omics (plasma lipidomic, metabolomic, and fecal 16 S microbiome) data-driven stratification and characterization to identify the metabolic at-risk profile within PWH. Through network analysis and similarity network fusion (SNF), we identified three groups of PWH (SNF-1-3): healthy (HC)-like (SNF-1), mild at-risk (SNF-3), and severe at-risk (SNF-2). The PWH in the SNF-2 (45%) had a severe at-risk metabolic profile with increased visceral adipose tissue, BMI, higher incidence of metabolic syndrome (MetS), and increased di- and triglycerides despite having higher CD4

Identifiants

pubmed: 36794912
doi: 10.7554/eLife.82785
pii: 82785
pmc: PMC10017104
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023, Mikaeloff et al.

Déclaration de conflit d'intérêts

FM, MG, RB, AK, BV, JH, JH, TB, DM, CG, AM, MT, SN, UN No competing interests declared

Références

Metabolites. 2019 Sep 30;9(10):
pubmed: 31574898
EBioMedicine. 2018 Apr;30:192-202
pubmed: 29650491
Curr Med Chem. 2016;23(37):4221-4230
pubmed: 27686657
PLoS One. 2021 Apr 27;16(4):e0250328
pubmed: 33905435
Front Immunol. 2022 Dec 20;13:1072720
pubmed: 36605218
Front Immunol. 2022 Jan 12;12:742736
pubmed: 35095835
J Open Source Softw. 2020;5(49):
pubmed: 36919162
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e638-e649
pubmed: 33053159
Metabolomics. 2018 Mar;14(3):
pubmed: 30760970
Protein Cell. 2021 May;12(5):360-373
pubmed: 33346905
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Clin Infect Dis. 2018 Aug 1;67(4):579-586
pubmed: 29471519
Clin Sci (Lond). 2019 Apr 29;133(8):997-1010
pubmed: 30952809
EBioMedicine. 2016 Jan 28;5:135-46
pubmed: 27077120
Nat Methods. 2014 Mar;11(3):333-7
pubmed: 24464287
Mol Nutr Food Res. 2021 Feb;65(4):e2000647
pubmed: 33325641
Cancers (Basel). 2021 May 21;13(11):
pubmed: 34064004
Commun Biol. 2022 Jan 11;5(1):27
pubmed: 35017663
J Int Assoc Provid AIDS Care. 2016 Mar-Apr;15(2):164-71
pubmed: 26514630
Curr HIV/AIDS Rep. 2019 Jun;16(3):214-223
pubmed: 30993515
Clin Exp Immunol. 2017 Jan;187(1):44-52
pubmed: 27198731
Gut. 2021 Jun;70(6):1174-1182
pubmed: 33272977
Nat Rev Microbiol. 2021 Feb;19(2):77-94
pubmed: 32968241
AIDS. 2018 Oct 23;32(16):2405-2416
pubmed: 30134296
Cell Syst. 2022 Aug 17;13(8):665-681.e4
pubmed: 35933992
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Curr Opin Virol. 2021 Aug;49:151-156
pubmed: 34144380
Annu Rev Med. 2011;62:141-55
pubmed: 21090961
Circulation. 2014 May 6;129(18):1821-31
pubmed: 24622385
Mucosal Immunol. 2021 Jan;14(1):113-124
pubmed: 32433514
Biomed Res Int. 2019 Feb 5;2019:2870647
pubmed: 30868068
Expert Opin Drug Saf. 2019 Sep;18(9):829-840
pubmed: 31304808
Clin Infect Dis. 2020 Nov 5;71(8):e359-e367
pubmed: 31894240
Aging (Albany NY). 2021 Oct 11;13(19):22732-22751
pubmed: 34635603
Cell Metab. 2017 Jul 5;26(1):110-130
pubmed: 28625867
Lipids Health Dis. 2016 Sep 06;15(1):149
pubmed: 27600391
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Front Immunol. 2021 Jun 15;12:693074
pubmed: 34211479
Front Cell Infect Microbiol. 2020 Sep 24;10:434
pubmed: 33102244
Front Oncol. 2020 Jun 30;10:1065
pubmed: 32714870
Clin Infect Dis. 2020 Feb 3;70(4):615-627
pubmed: 30921452
Eur Respir J. 2021 Aug 26;58(2):
pubmed: 34140302
Gut Microbes. 2022 Jan-Dec;14(1):2073131
pubmed: 35574937
Rev Endocr Metab Disord. 2019 Dec;20(4):461-472
pubmed: 31707624
J Infect Chemother. 2017 Jan;23(1):12-16
pubmed: 27825722
Nat Commun. 2020 May 15;11(1):2448
pubmed: 32415070
Emerg Microbes Infect. 2016 Apr 06;5:e31
pubmed: 27048741
Nat Rev Microbiol. 2018 Jul;16(7):410-422
pubmed: 29795328
Mol Syst Biol. 2018 Jun 20;14(6):e8124
pubmed: 29925568

Auteurs

Flora Mikaeloff (F)

The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

Marco Gelpi (M)

Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Rui Benfeitas (R)

National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Andreas D Knudsen (AD)

Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Beate Vestad (B)

Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Norwegian PSC Research Center, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Julie Høgh (J)

Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Johannes R Hov (JR)

Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Norwegian PSC Research Center, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Thomas Benfield (T)

Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.

Daniel Murray (D)

Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Christian G Giske (CG)

Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Adil Mardinoglu (A)

Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom.

Marius Trøseid (M)

Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Institute of Clinical Medicine, Oslo, Norway.

Susanne D Nielsen (SD)

Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Ujjwal Neogi (U)

The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH